Research programme: c-Kit inhibitors - Plexxikon/Phenomix
Alternative Names: c-Kit inhibitors research programme - Plexxikon/Phenomix; PLX 647Latest Information Update: 05 Mar 2008
At a glance
- Originator Phenomix Corporation; Plexxikon
- Class Small molecules
- Mechanism of Action Macrophage colony-stimulating factor receptor antagonists; Proto-oncogene protein c-kit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypersensitivity; Inflammation; Multiple sclerosis; Rheumatoid arthritis
Most Recent Events
- 05 Mar 2008 Discontinued - Preclinical for Allergy in USA (unspecified route)
- 05 Mar 2008 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 05 Mar 2008 Discontinued - Preclinical for Multiple sclerosis in USA (unspecified route)